FDA Adverse Event Injury Summary report: N

FINELINE II

MDR report key: 2911955 · Received January 11, 2013

Report

Report Number
2124215-2012-16529
Event Type
Injury
Date Received
January 11, 2013
Date of Event
December 4, 2012
Report Date
January 15, 2013
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE PRODUCT IS EXPECTED TO BE RETURNED FOR ANALYSIS. THIS REPORT WILL BE UPDATED UPON RETURN AND COMPLETION OF ANALYSIS.

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A THOROUGH EVALUATION OF THE LEAD WAS PERFORMED. RESISTANCE TESTS WERE COMPLETED TO ASSESS LEAD ELECTRICAL PERFORMANCE. MEASUREMENTS THROUGHOUT THESE TESTS WERE WITHIN NORMAL LIMITS. VISUAL INSPECTION NOTED THE EXTRACTING STYLET WAS RETURNED IN THE LEAD LUMEN. MICROSCOPIC INSPECTIONS OF THE TERMINAL PIN ASSEMBLY, LEAD BODY, AND ELECTRODE TIP FOUND NO ANOMALIES WHICH WOULD HAVE CAUSED DISLODGEMENT. LABORATORY TESTING WAS UNABLE TO REPRODUCE THE REPORTED CLINICAL OBSERVATIONS.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR (RV) LEAD EXHIBITED INTERMITTENT LOSS OF CAPTURE DUE TO LEAD DISLODGEMENT. AN INVASIVE PROCEDURE WAS PERFORMED AND THE LEAD WAS REPOSITIONED. THE FOLLOWING DAY, LOSS OF CAPTURE AT MAXIMUM OUTPUTS WAS OBSERVED. THE POCKET WAS REOPENED AND THIS LEAD WAS EXPLANTED. A NEW LEAD WAS SUCCESSFULLY IMPLANTED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
17127 FINELINE II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4470

Patients

Seq Age Sex Outcome Treatment
1 64 YR Hospitalization| L| R 4470| MISMATCH| K173| 1290| 1388TC| 4135